Technology Transfer Licensing Opportunity: Diagnostic Kit to Detect Human Infertility

The U.S. Environmental Protection Agency (EPA) is offering a technology transfer licensing opportunity for a diagnostic kit to detect human infertility. The kit is based on the Sperm Membrane Protein 22 (SP22), which is highly correlated with fertility in humans. The technology has been developed by EPA inventor Gary Klinefelter and has been patented (U.S. Patent 8,497,135). The kit presents an opportunity for more reliable male fertility testing and can be used in various applications, including human fertility testing, human fertility research, and comparative biology research. • The kit detects SP22 in a motile semen sample using one of seven sequence IDs listed in the patent. • The technology has been developed to create a custom antibody synthesized for use in the patented kit. • The improved kit provides an opportunity for more reliable male fertility testing when used to identify human gene sequence expression of SP22. • The technology has potential applications in human fertility testing, human fertility research, and comparative biology research.